-
HyperScribe™ T7 RNA Labeling Workflow
2026-09-28
Use fluorescein-labeled RNA to connect SlCAT2 transcript measurements with the protein-centered defense mechanism reported in Tuta absoluta research. This workflow shows how HyperScribe™ T7 High Yield Fluorescein RNA Labeling Kit can support probe generation for hybridization, transcript localization, and orthogonal validation while avoiding overinterpretation of RNA abundance as catalase activity.
-
HMGB1 Proteomics for Early Diabetic Nephropathy
2026-09-28
A serum quantitative-proteomics study identified protein patterns associated with diabetic nephropathy progression and prioritized HMGB1 as a candidate for early monitoring. Its integration of stage-related clustering with co-expression analysis, followed by cell and animal validation under high-glucose conditions, provides a discovery framework—not yet a clinically validated diagnostic test.
-
EZ Cap™ Firefly Luciferase mRNA: Assay Guide
2026-09-27
A practical guide to using EZ Cap™ Firefly Luciferase mRNA (SKU R1018) in cell-based reporter and viability workflows. It covers assay design, RNA handling, interpretation, and what citrate-buffer research does—and does not—tell us about formulation choices.
-
gamma-Glu-Cys (γ-Glu-Cys): Workflow Guide
2026-09-26
gamma-Glu-Cys (γ-Glu-Cys) provides a defined intermediate for glutathione synthetase assays, glutathione metabolism research, and phytochelcin-related studies. Use it in controlled laboratory workflows with appropriate enzyme and matrix controls; it is not intended for diagnostic, medical, or clinical use.
-
PD98059 for MAPK/ERK Pathway Assays
2026-09-25
Use PD98059 to test whether MEK–ERK signaling contributes to stimulus-driven lipid accumulation, proliferation, or cell-death phenotypes. A recent vascular toxicology study demonstrates its value alongside UHRF1 knockdown, while this guide translates that strategy into a controlled, troubleshooting-aware workflow.
-
Berbamine Hydrochloride in HCC Assay Design
2026-09-25
Explore how Berbamine hydrochloride can be positioned in cancer research without conflating pathway inhibition with ferroptosis. This assay-design perspective connects its reported pharmacology to the METTL16–SENP3–LTF findings in HCC and highlights the controls needed to interpret results.
-
Cy5-UTP for Mapping Antiviral RNA Foci
2026-09-24
Cy5-UTP enables fluorescent RNA probe synthesis for asking a more specific question than whether a transcript is present: where it accumulates during antiviral stress. This article connects Cyanine 5-uridine triphosphate to the GADD34 mRNA sequestration mechanism reported in SARS-CoV-2 research, while distinguishing established findings from proposed assay applications.
-
Linezolid: Mechanism, Evidence, and Research Use
2026-09-24
Linezolid is an oxazolidinone antimicrobial that inhibits bacterial protein synthesis by binding the 50S ribosomal subunit. This research overview summarizes its reported activity against resistant Gram-positive bacteria, key product specifications, assay-data limitations, and appropriate boundaries for interpreting the evidence.
-
FOXM1 and Female Lung Adenocarcinoma: Study Insights
2026-09-23
A 2023 Research Square study combines TCGA and GEO analyses with cell experiments to investigate FOXM1 in female lung adenocarcinoma. It reports elevated FOXM1, links its expression with clinical and survival features, and identifies experimental and computational leads involving miR-204-5p, estrogen receptor 1, and predicted immunotherapy sensitivity.
-
Dinaciclib (SCH727965) in Cell Assays
2026-09-23
This scenario-driven guide explains how Dinaciclib (SCH727965), SKU A8412, can improve interpretation of viability, cell-cycle, and apoptosis experiments. It covers mechanism-aware assay design, solvent and stock handling, tissue-boundary applications, and practical criteria for evaluating supplier reliability.
-
Angiotensin III: A Sequence-Aware Assay Guide
2026-09-22
Angiotensin III is a sequence-defined RAAS peptide for resolving aldosterone, renin, receptor, and pressor biology. This guide connects its validated product attributes with a recent spike–receptor binding study to improve assay design without overstating translational evidence.
-
EZ Cap™ Cy5 EGFP mRNA (5-moUTP) Workflow
2026-09-22
Separate nanoparticle uptake from productive translation with one Cy5-labeled mRNA reagent and an EGFP functional readout. This practical workflow supports targeted LNP screening, macrophage studies, and quantitative optimization without relying on secondary mRNA detection.
-
L-Threonine: Metabolic Context for ALP Assays
2026-09-21
L-Threonine is an essential amino acid with important roles in protein synthesis, nutrient signaling, and metabolic profiling. This article presents a decision framework for using threonine biology alongside metal-free nanozyme-based alkaline phosphatase assays without confusing nutritional effects with direct enzyme inhibition.
-
EdU Flow Cytometry Assay Kits (Cy5) Workflow Guide
2026-09-21
EdU Flow Cytometry Assay Kits (Cy5) convert short DNA-replication pulses into quantitative, multiplex-compatible flow cytometry data. This workflow guide shows how to apply the assay to cancer cell proliferation, genotoxicity, and pharmacodynamic studies while avoiding common fixation, click-reaction, and Cy5 compensation errors.
-
CX-5461 Drives Mitotic Catastrophe in Cervical Cancer
2026-09-20
The reference study shows that the RNA polymerase I inhibitor CX-5461 suppresses cervical cancer cell growth by coupling DNA damage and ATM/ATR activation to aberrant mitotic entry. Its ability to enhance cisplatin sensitivity provides a mechanistic rationale for investigating Pol I inhibition in treatment-resistant cervical cancer, while also highlighting the need for careful validation in resistant and in vivo models.